Annual Drug Patent Expirations for REQUIP+XL
Requip Xl is a drug marketed by Glaxosmithkline Llc and is included in one NDA. There are two patents protecting this drug and seven Paragraph IV challenges.
This drug has forty-eight patent family members in twenty-seven countries.
The generic ingredient in REQUIP XL is ropinirole hydrochloride. Additional details are available on the ropinirole hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
